Highlights and Quick Summary
- Annual Depreciation/Fixed assets for 2022 was 0.75 (a 90.55% increase from previous year)
- Annual Depreciation/Fixed assets for 2022 was 0.39 (a -35.91% decrease from previous year)
- Annual Depreciation/Fixed assets for 2021 was 0.62 (a -16.17% decrease from previous year)
- Twelve month Depreciation/Fixed assets ending December 31, 2022 was 1.03 (a 17.3% increase compared to previous quarter)
- Twelve month trailing Depreciation/Fixed assets increased by 3.37% year-over-year
Trailing Depreciation/Fixed assets for the last four month:
31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
---|---|---|---|
1.03 | 0.88 | 0.75 | 1.0 |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Depreciation/Fixed assets of Benitec Biopharma Limited
Most recent Depreciation/Fixed assetsof BNTC including historical data for past 10 years.Interactive Chart of Depreciation/Fixed assets of Benitec Biopharma Limited
Benitec Biopharma Limited Depreciation/Fixed assets for the past 10 Years (both Annual and Quarterly)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | – | – | – | – | 0.75 |
2021 | – | – | – | – | 0.62 |
2020 | – | – | – | – | 0.51 |
2019 | – | – | – | – | 0.34 |
2018 | – | – | – | – | 0.61 |
2017 | – | – | – | – | 0.0 |
2016 | – | – | – | – | 0.57 |
2015 | – | – | – | – | 0.21 |
2014 | – | – | – | – | 0.27 |
2013 | – | – | – | – | 1.06 |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology